[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.

입력 : 2021-12-06 (23:35:15) | 수정 : 2026-02-14 (09:05:25)

[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.

The highly anticipated FDA approval for Sensonics Holdings, a leading medical technology company, has been hit with a significant delay. This setback is expected to have a direct impact on the company's profits in the near future, causing concern among investors and stakeholders. The delay in FDA approval is likely to disrupt Sensonics' plans for product development and market entry. This news comes as a blow to the company, which has been eagerly awaiting the green light to launch its innovative medical devices. According to sources close to the matter, the next application for FDA approval is not expected until 2023, a...

[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years. [More News]

[ NEWS ] [ SENS ] The FDA approval of Sensonics Holdings has been delayed . This is expected to interfere with profits for the time being , and the next application is scheduled for 2023 in two years .

[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.

[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.